Skip to main content
Clinical Trials/NCT06467149
NCT06467149
Recruiting
N/A

Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools

Ju Qiu1 site in 1 country500 target enrollmentAugust 12, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Frailty Syndrome
Sponsor
Ju Qiu
Enrollment
500
Locations
1
Primary Endpoint
Unplanned hospitalisation
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.

Registry
clinicaltrials.gov
Start Date
August 12, 2023
End Date
December 30, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Ju Qiu
Responsible Party
Sponsor Investigator
Principal Investigator

Ju Qiu

lecturer.

Chongqing Medical University

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of breast cancer
  • Age ≥50 years old
  • the treatment plan discussed by MDT includes surgery and chemotherapy
  • can walk on their own (with the assistance of walking aids)

Exclusion Criteria

  • Communication disorders
  • Mental disorders that can't cooperate normally
  • Combined with other malignant tumours
  • Terminal stage of the disease

Outcomes

Primary Outcomes

Unplanned hospitalisation

Time Frame: 2023.8~2025.12.

hospitalisation after doctor's diagnosis and hospitalisation for more than one day after diagnosis of breast cancer up to the second follow-up period, except for treatment nodes such as surgery and chemotherapy.No scale is used, it is a dichotomous variable with a score of "1" for unplanned hospitalisation and a score of "0" for non-occurrence.

Disability

Time Frame: From 2023.8~2025.12.

Activities of daily living (ADL) were assessed using the Barthel Index (BI).The present study defined the development of disability as a decrease in scores on at least one scale entry in the BI scale from six months earlier

Falls

Time Frame: From 2023.8~2025.12.

one or more falls due to various reasons between the diagnosis of breast cancer and the second follow-up period.Does not use any scale, is a dichotomous variable with a fall score of "1" and a no fall score of "0".

Depression

Time Frame: From 2023.8~2025.12.

Depression screening was performed using the Geriatric Depression Scales-5 (GDS-5). The options for each entry were "yes" or "no". Entry 1 was scored 0 points for "yes" and 1 point for "no", and entries 2 to 5 were scored 1 point for "yes" and 0 points for "no". The answer "yes" for entries 2 to 5 is 1 point, and the answer "no" is 0 points. The total score ranged from 0 to 5, with a score of ≥2 indicating the presence of depression.

Study Sites (1)

Loading locations...

Similar Trials